Paul H Marks1, Michelle L Cameron Donaldson. 1. Department of Orthopaedic Surgery, University of Toronto, Orthopaedic and Arthritic Institute, Toronto, Ontario, Canada.
Abstract
PURPOSE: Patients with chronic anterior cruciate ligament (ACL) deficiency are at high risk of articular cartilage damage and the development of osteoarthritis (OA). It has been hypothesized that biochemical factors, such as cytokines, contribute to the process. The purpose of our study was to determine the concentrations of potentially chondrodestructive and chondroprotective cytokines in the chronic ACL-deficient knee, and to determine if the cytokine profile or other factors correlated with the amount of chondral damage present in the knee. TYPE OF STUDY: A consecutive series of patients who consented to the Institutional Review Board-approved study. METHODS: Synovial fluid lavages were obtained from 31 patients with ACL-deficient knees. Four patients had lavages aspirated from their contralateral normal knee. These lavages were analyzed for interleukin (IL)-1alpha, IL-1beta, IL-1ra, and tumor necrosis factor (TNF)-alpha. At arthroscopy, the amount of chondral damage was graded based on the Outerbridge classification. RESULTS: Concentrations of chondrodestructive IL-1beta and TNF-alpha were significantly higher in patients with ACL ruptures than in the contralateral normal knees. The more severe the chondral damage, the higher the concentration of IL-1beta and TNF-alpha. Chondroprotective cytokine concentrations decreased with increasing grades of chondral damage. We found a linear correlation between the severity of chondral damage and the time from injury (r2 = .954). CONCLUSIONS: A difference was seen in the cytokine profiles between the normal and injured knees. This difference varied based on the severity of chondral damage, which was associated with time from injury. CLINICAL RELEVANCE: Cytokine levels are associated with chondral damage.
PURPOSE:Patients with chronic anterior cruciate ligament (ACL) deficiency are at high risk of articular cartilage damage and the development of osteoarthritis (OA). It has been hypothesized that biochemical factors, such as cytokines, contribute to the process. The purpose of our study was to determine the concentrations of potentially chondrodestructive and chondroprotective cytokines in the chronic ACL-deficient knee, and to determine if the cytokine profile or other factors correlated with the amount of chondral damage present in the knee. TYPE OF STUDY: A consecutive series of patients who consented to the Institutional Review Board-approved study. METHODS: Synovial fluid lavages were obtained from 31 patients with ACL-deficient knees. Four patients had lavages aspirated from their contralateral normal knee. These lavages were analyzed for interleukin (IL)-1alpha, IL-1beta, IL-1ra, and tumor necrosis factor (TNF)-alpha. At arthroscopy, the amount of chondral damage was graded based on the Outerbridge classification. RESULTS: Concentrations of chondrodestructive IL-1beta and TNF-alpha were significantly higher in patients with ACL ruptures than in the contralateral normal knees. The more severe the chondral damage, the higher the concentration of IL-1beta and TNF-alpha. Chondroprotective cytokine concentrations decreased with increasing grades of chondral damage. We found a linear correlation between the severity of chondral damage and the time from injury (r2 = .954). CONCLUSIONS: A difference was seen in the cytokine profiles between the normal and injured knees. This difference varied based on the severity of chondral damage, which was associated with time from injury. CLINICAL RELEVANCE: Cytokine levels are associated with chondral damage.
Authors: Alexander A Theologis; Daniel Kuo; Jonathan Cheng; Radu I Bolbos; Julio Carballido-Gamio; C Benjamin Ma; Xiaojuan Li Journal: Arthroscopy Date: 2010-10-29 Impact factor: 4.772
Authors: Heenam Kwon; Roshni S Rainbow; Lin Sun; Carrie K Hui; Dana M Cairns; Rucsanda C Preda; David L Kaplan; Li Zeng Journal: J Biomed Mater Res A Date: 2014-05-03 Impact factor: 4.396
Authors: B Moradi; N Rosshirt; E Tripel; J Kirsch; A Barié; F Zeifang; T Gotterbarm; S Hagmann Journal: Clin Exp Immunol Date: 2015-04 Impact factor: 4.330
Authors: Kyle P Harris; Jeffrey B Driban; Michael R Sitler; Nicole M Cattano; Easwaran Balasubramanian; Jennifer M Hootman Journal: J Athl Train Date: 2015-06-26 Impact factor: 2.860
Authors: K A Kimmerling; B D Furman; D S Mangiapani; M A Moverman; S M Sinclair; J L Huebner; A Chilkoti; V B Kraus; L A Setton; F Guilak; S A Olson Journal: Eur Cell Mater Date: 2015-01-31 Impact factor: 3.942
Authors: Megan E Blewis; Brian J Lao; Kyle D Jadin; William J McCarty; William D Bugbee; Gary S Firestein; Robert L Sah Journal: Biotechnol Bioeng Date: 2010-05-01 Impact factor: 4.530
Authors: Megan E Blewis; Brian J Lao; Barbara L Schumacher; William D Bugbee; Robert L Sah; Gary S Firestein Journal: Tissue Eng Part A Date: 2010-04 Impact factor: 3.845
Authors: Eric G Lima; Andrea R Tan; Timon Tai; Liming Bian; Gerard A Ateshian; James L Cook; Clark T Hung Journal: J Biomech Date: 2008-09-26 Impact factor: 2.712